BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3132191)

  • 1. Biochemical assessment of acute and chronic treatment of Paget's bone disease with calcitonin and calcium with and without biphosphonate.
    Rico H; Hernández ER; Younes M; Hernández D; Espinós D
    Bone; 1988; 9(1):63-6. PubMed ID: 3132191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Fraser TR; Ibbertson HK; Holdaway IM; Rutland M; King A; Dodd G; Wattie DJ
    Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study].
    Eisinger J; Laponche AM; Ouaniche J
    Rev Rhum Mal Osteoartic; 1986 Mar; 53(3):183-5. PubMed ID: 3085204
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease.
    O'Donoghue DJ; Hosking DJ
    Bone; 1987; 8(4):219-25. PubMed ID: 3128315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
    Jaeger P; Bischoff-Delaloye A; Burckhardt P
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M; Khairi A; Johnston C
    Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Paget's disease of bone.
    Evans RA
    Med J Aust; 1983 Feb; 1(4):159-62. PubMed ID: 6405139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
    Miravet L; Kuntz D
    Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):287-92. PubMed ID: 2496460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcitonin or EHDP in Paget's disease?
    Bijvoet OL; Hosking DJ; Van Aken J; Will EJ
    Calcif Tissue Res; 1977 May; 22 Suppl():494. PubMed ID: 410489
    [No Abstract]   [Full Text] [Related]  

  • 11. Paget's bone disease treated with diphosphonate and calcitonin.
    Hosking DJ; Bijvoet OL; van Aken J; Will EJ
    Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biochemical effects of EHDP in Paget's disease of bone: patterns of response to initial treatment and to long-term therapy.
    Siris ES; Canfield RE; Jacobs TP; Stoddart KE; Spector PJ
    Metab Bone Dis Relat Res; 1981; 3(4-5):301-8. PubMed ID: 6820111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.
    Evans RA; Somers NM; Dunstan CR; Hills E; Evans M
    Calcif Tissue Int; 1991 Sep; 49(3):164-7. PubMed ID: 1933580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
    Sieghart S
    Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of the therapeutic sequence calcitonin-EHDP in Paget's disease].
    Eisinger J; Schiano A; d'Omezon Y; Ouaniche J
    Rev Rhum Mal Osteoartic; 1983 Mar; 50(3):245-6. PubMed ID: 6408727
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcitonin and diphosphonate in the treatment of Paget's disease of bone.
    Hosking DJ
    Metab Bone Dis Relat Res; 1981; 3(4-5):317-26. PubMed ID: 6820113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of Paget's disease of bone].
    Mimura K
    Nihon Seikeigeka Gakkai Zasshi; 1985 Aug; 59(8):751-61. PubMed ID: 3936894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procollagen-III peptide serum levels in Paget's disease of the bone.
    Wilder-Smith CH; Raue F; Holz-Gottswinter G; Ziegler R
    Klin Wochenschr; 1987 Feb; 65(4):174-8. PubMed ID: 3104661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.